Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-06-15 16:32:34
Reporting Period:
Accepted Time:
2018-06-15 16:32:34
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453022 Anthony Laplaca One Invacare Way
Elyria OH 44035
Sr. Vp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2018-06-14 20,000 $16.55 64,385 No 4 M Direct
Common Shares Disposition 2018-06-14 20,000 $19.59 44,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2018-06-14 20,000 $0.00 20,000 $16.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
66,700 2018-10-27 No 4 M Direct
  1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.507 - $19.675. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. This option vested equally on September 30, 2009, 2010, 2011 and 2012.
  3. The reporting person holds previously reported options to buy 66,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 19, 2009 and March 18, 2013, at exercise prices between $13.37 to $25.24 per share, will expire between August 19, 2019 and March 18, 2023, and became exercisable between September 30, 2010 and March 31, 2017.